Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
Imaging Review of the Temporal Bone: Part II. Traumatic, Postoperative, and Noninflammatory Nonneoplastic Conditions.
Parameters of consultee satisfaction with inpatient academic psychiatric consultation services: a multicenter study.
Restoring the sense of touch with a prosthetic hand through a brain interface.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer. Clin Cancer Res. 2015 Jul 01; 21(13):2911-5.
View in:
PubMed
subject areas
Breast Neoplasms
Chemotherapy, Adjuvant
Clinical Trials as Topic
Drug Discovery
Female
Humans
Neoadjuvant Therapy
Treatment Outcome
authors with profiles
Olufunmilayo Olopade
Rita Nanda